187 related articles for article (PubMed ID: 11841606)
1. Recent advances in recombinant adeno-associated virus vector production.
Clark KR
Kidney Int; 2002 Jan; 61(1 Suppl):S9-15. PubMed ID: 11841606
[TBL] [Abstract][Full Text] [Related]
2. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
3. Cell lines for the production of recombinant adeno-associated virus.
Clark KR; Voulgaropoulou F; Fraley DM; Johnson PR
Hum Gene Ther; 1995 Oct; 6(10):1329-41. PubMed ID: 8590738
[TBL] [Abstract][Full Text] [Related]
4. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
[TBL] [Abstract][Full Text] [Related]
5. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
6. Insect cells as a factory to produce adeno-associated virus type 2 vectors.
Urabe M; Ding C; Kotin RM
Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
Hallek M; Wendtner CM
Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
[TBL] [Abstract][Full Text] [Related]
8. Production and purification of recombinant adeno-associated vectors.
Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
[TBL] [Abstract][Full Text] [Related]
9. High throughput production, screening and analysis of adeno-associated viral vectors.
Drittanti L; Rivet C; Manceau P; Danos O; Vega M
Gene Ther; 2000 Jun; 7(11):924-9. PubMed ID: 10849551
[TBL] [Abstract][Full Text] [Related]
10. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).
O'Riordan CR; Lachapelle AL; Vincent KA; Wadsworth SC
J Gene Med; 2000; 2(6):444-54. PubMed ID: 11199265
[TBL] [Abstract][Full Text] [Related]
11. Production of recombinant adeno-associated virus vectors.
Zolotukhin S
Hum Gene Ther; 2005 May; 16(5):551-7. PubMed ID: 15916480
[TBL] [Abstract][Full Text] [Related]
12. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
13. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
Clark KR; Voulgaropoulou F; Johnson PR
Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
Grieger JC; Samulski RJ
Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
[TBL] [Abstract][Full Text] [Related]
15. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated viral vectors for gene transfer and gene therapy.
Büeler H
Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
[TBL] [Abstract][Full Text] [Related]
17. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
Shiau AL; Liu PS; Wu CL
J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
[TBL] [Abstract][Full Text] [Related]
18. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
Grieger JC; Soltys SM; Samulski RJ
Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
[TBL] [Abstract][Full Text] [Related]
19. Toward exascale production of recombinant adeno-associated virus for gene transfer applications.
Cecchini S; Negrete A; Kotin RM
Gene Ther; 2008 Jun; 15(11):823-30. PubMed ID: 18401433
[TBL] [Abstract][Full Text] [Related]
20. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
